Phesgo is a combination medication containing pertuzumab, trastuzumab, and hyaluronidase or hyaluronidase-zzxf. It's a targeted anticancer treatment for HER2-positive breast cancer that’s either in the early or metastatic stage. Phesgo is an injection that’s given under the skin, and it’s typically used along with other chemotherapy. But people who receive this treatment plan commonly experience hair loss, nausea, and diarrhea.
HER2-positive breast cancers, together with other chemotherapy
Phesgo is a combination of three medications.
Pertuzumab and trastuzumab are monoclonal antibodies that act as a human epidermal growth factor receptor 2 (HER2) inhibitor. It blocks a specific protein in the body that’s important for cell growth called HER2. HER2 is found on both normal and cancer cells. Cancer cells usually have more HER2 proteins than normal cells. This can cause cancer cells to grow more quickly than normal cells. When HER2 is blocked by Phesgo, cancer cells can’t grow and spread as well.
Hyaluronidase is a protein that helps your body absorb pertuzumab and trastuzumab better when injected under the skin.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Preferred first-choice treatment option for HER2-positive advanced breast cancer
Only one injection that’s given under the skin, rather than two separate infusions of Herceptin (trastuzumab) and Perjeta (pertuzumab) into the vein
Injection only takes about 5 to 8 minutes to administer
Commonly causes diarrhea
Must use together with additional chemotherapy, so it’s not a single-medication treatment plan for breast cancer
Requires administration from a healthcare provider
Stay on track with your Phesgo injections. You can put your appointment dates into your calendar to help you remember when to get your dose. If you miss a dose, contact your provider so they can make changes to your treatment plan if needed. If it’s been at least 6 weeks since your last injection, your provider might need to adjust your dose.
Phesgo is injected under the skin on the thigh. When you go to get your injection, wear loose shorts or a skirt so your provider can easily inject the medication.
You might experience a reaction during or shortly after your Phesgo injection. Expect to stay at your provider’s office or infusion center for 15 to 30 minutes after your injection so your care team can watch for reactions. Tell your provider right away if you experience any infusion reactions like fever, chills, headache, or vomiting.
Diarrhea is a common side effect of Phesgo. To lower your risk, avoid foods that are greasy, fatty, or spicy. It’s also helpful to eat small, frequent meals. Also, be sure to stay hydrated by drinking plenty of clear, noncarbonated drinks.
You’ll need regular monitoring of your heart while receiving Phesgo and for two years after your last dose. This is because Phesgo can cause heart failure and other heart problems. Make sure to let your provider know if you experience any new or worsening shortness of breath, cough, swelling of your legs or feet, sudden weight gain, racing heartbeat, or dizziness. These can be signs of heart problems, and you might need to stop taking this medication.
If you’re a female who can get pregnant, you should use birth control while receiving Phesgo and for 7 months after the last dose. This medication can cause harm to an unborn baby. Let your provider know right away if you become pregnant during Phesgo treatment.
Phesgo can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Receiving Phesgo with other heart-damaging anticancer medications
Phesgo can cause new or worsening heart failure and affect how well your heart pumps blood through your body. It can also cause high blood pressure, irregular heartbeats, or in serious cases, death related to a heart problem. Your risk of heart problems is higher if you’re receiving Phesgo with other heart-damaging anticancer medications or if you have other heart problems. Make sure your provider has your full medical history, so they can closely monitor your heart through imaging using an echocardiogram or a MUGA scan. You’ll need to get this scan before starting treatment, about every 3 months while receiving Phesgo, and every 6 months for 2 years after you complete treatment. Let your care team know if you experience any signs and symptoms of heart failure, including shortness of breath, dry cough, irregular heartbeats, chest pain, or weight gain.
Risk factors: History of lung problems | Cancer tumors in the lung
It’s possible for Phesgo to cause rare, but serious, lung problems, including inflammation of the lungs and fluid buildup in the lungs. Let your provider know if you have difficulty breathing, cough, or fatigue during your treatment.
Phesgo might cause harm to an unborn baby. If you're a female who’s able to become pregnant, your provider might check to see if you’re pregnant before you start treatment. Use birth control while you’re receiving Phesgo and for at least 7 months after your last dose. Let your provider know right away if you or your partner become pregnant during this time.
People receiving Phesgo together with bone marrow-suppressing chemotherapy had lower white blood cell counts compared to those receiving chemotherapy alone. White blood cells help fight off infections, so having low white blood cell levels can raise the risk of developing infections. Let your provider know as soon as possible if you experience fevers, chills, or any sign of infection.
Risk factors: Breathing problems
People receiving Phesgo might experience allergic reactions, which can sometimes be serious. Your provider will observe you for 30 minutes after your first injection to watch out for any symptoms of a reaction. But they’ll only need to observe you for 15 minutes after the rest of your injections. Alert your provider or get medical help right away if you experience any symptom of an allergic reaction. Symptoms include dizziness, nausea, fever, chills, itchy skin, chest pain, and trouble breathing. If a reaction happens, your healthcare provider can slow down or stop the injection. They can also give you certain medication (like antihistamines or anti-fever medications) before your next injections.
Phesgo is given by a healthcare provider as an injection under the skin on the thigh. After the first dose, it’s given once every 3 weeks.
For the first dose, you’ll get 1,200 mg of pertuzumab, 600 mg of trastuzumab, and 30,000 units of hyaluronidase.
For all other doses, you’ll get 600 mg of pertuzumab, 600 mg of trastuzumab, and 20,000 units of hyaluronidase.
HER2-positive, breast cancers - IV and SQ injections
HER2-positive, metastatic stomach cancer - IV injection only
HER2-positive breast cancers, together with Herceptin (trastuzumab) and chemotherapy
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.